Informations sur le produit
SSR 149415 is an orally active small molecule that inhibits the activity of receptor tyrosine kinases (RTKs) and can be used to treat autoimmune diseases. SSR 149415 has been shown to inhibit the expression of osteogenic genes in cells. It has also been shown to inhibit the proliferation of prostate cancer cells by binding to the RTKs and inhibiting their downstream signaling pathways. The molecule has been shown to have a high affinity for asymmetric synthesis, which makes it more stable than other molecules. SSR 149415 has been found to bind specifically with polymorphic regions on a number of different proteins, which may make it useful for diagnostic purposes.
SSR 149415 was shown to block dopamine release from striatal neurons in cell culture studies, indicating that this drug may be useful in treating Parkinson’s disease.
Propriétés chimiques
Question d’ordre technique sur : 3D-PSA68769 SSR 149415
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
